TSE:MFC

Manulife Financial (MFC.TO)

61.18
+1.26 (2.10%)
as of Sep 3, 2026, 5:07:12 pm Market Open.
1632 watching
0
Investor Insights
star iconSep 3, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial is navigating a complex landscape marked by both growth opportunities and challenges. While the company has reported a strong quarter and shows healthy growth, particularly in Asia and wealth management, concerns exist surrounding the newly imposed tax by the Chinese government on its products. The stock's valuation is drawing mixed reactions, with some experts noting it's currently overbought and trading above 2x book value. However, many analysts maintain a positive outlook, emphasizing its steady dividend yield and potential for long-term growth, particularly if macroeconomic conditions shift in its favor. Despite some recent underperformance compared to peers, strong fundamentals and a reliable business model position Manulife well for the future.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
TOP PICK
John Hancock is a good strategic acquisition/merger. Valuation is very attractive. Stock will remain under pressure for a while.
BUY
The John Hancock acquisition is a good platform for the US. Will take two years to consolidate so may not move very much. Should be a great core holding.
DON'T BUY
Likes the company but would like it at a lower price.
WEAK BUY
Financials are performing quite well. Would prefer Great West life.
BUY
A buying opportunity. Model price is $10/12 higher than the current price. The John Hancock deal was quite cheap.
TOP PICK
Stock is down 10% on the announcement of the John Hancock deal. The deal itself will be 8/10% accretive in the first year. Trading at less than 10 X earnings, which make it a compelling buy.
WAIT
Their acquisition is very good, but the stock will be under some pressure because of the arbitrage and, after the deal closes, expect some US institutional shareholders may not have a mandate to hold Canadian stocks.
TOP PICK
The John Hancock acquisition was great. The weakness in the stock price makes it a good time to buy.
TOP PICK
Has dropped because of their purchase of John Hancock and you are getting it at less than 10 X earnings.
TOP PICK
Likes the acquisition of John Hancock in the US. Extremely well managed company. At a good price.
WAIT
The acquisition of John Hancock was a huge win for the long-term prospects. The stock will probably stall over the next 6 months.
BUY ON WEAKNESS
John Hancock acquisition was bought at a fair price. Synergies seem logical. Good management. US shareholders of John Hancock's will probably sell their shares which could give a real opportunity. Buy in the mid-$30.
BUY
Insurance sector is doing much better than earlier in the year. Looks attractive with their international exposure. Good yield. Solid balance sheet.
BUY
A core holding.
PAST TOP PICK
(Was a top pick June 12/03. Up 10%.) Still likes. Well positioned in their business in both the US and Asia. Disciplined management.
Showing 2,071 to 2,085 of 2,284 entries